The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex

被引:27
作者
Aasland, D [1 ]
Oppmann, B [1 ]
Grötzinger, J [1 ]
Rose-John, S [1 ]
Kallen, KJ [1 ]
机构
[1] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany
关键词
LIF; OSM; cytokines; cytokine receptors; ligand binding;
D O I
10.1006/jmbi.2001.5282
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To elucidate the function of the two cytokine-binding modules (CBM) of the leukemia inhibitory factor receptor (LIFR), receptor chimeras of LIFR and the interleukin-6 receptor (IL-6R) were constructed. Either the NH2- terminal (chimera RILLIFDeltaI) or the COOH-terminal LIFR CBM (chimera RILLIFDeltaII) were replaced by the structurally related CBM of the IL-6R which does not bind LIF. Chimera RILLIFDeltaI is functionally inactive, whereas RILLIFDeltaII binds LIF and mediates signalling as efficiently as the wild-type LIFR. Deletion mutants of the LIFR revealed that both the NH2-terminal CBM and the Ig-like domain of the LIFR are involved in LIF binding, presumably via the LIF site III epitope. The main function of the COOH-terminal CBM of the LIFR is to position the NH2-terminal CBM and the Ig-like domain, so that these can bind to LIF. In analogy to a recently published model of the IL-6R complex, a model of the active LIFR complex is suggested which positions the COOH-terminal CBM at LIF site I and the NH2-terminal CBM and the Ig-like domain at site III. An additional contact is postulated between the Ig-like domain of gp130 and the NH2-terminal CBM of the LIFR. (C) 2002 Academic Press.
引用
收藏
页码:637 / 646
页数:10
相关论文
共 75 条
[1]  
ALI SA, 1995, BIOTECHNIQUES, V18, P746
[2]   Mesenchymal to epithelial conversion in rat metanephros is induced by LIF [J].
Barasch, J ;
Yang, J ;
Ware, CB ;
Taga, T ;
Yoshida, K ;
Erdjument-Bromage, H ;
Tempst, P ;
Parravicini, E ;
Malach, S ;
Aranoff, T ;
Oliver, JA .
CELL, 1999, 99 (04) :377-386
[3]   NEUROPOIETIC CYTOKINES IN THE HEMATOPOIETIC FOLD [J].
BAZAN, JF .
NEURON, 1991, 7 (02) :197-208
[4]   HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES [J].
BAZAN, JF .
IMMUNOLOGY TODAY, 1990, 11 (10) :350-354
[6]   Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects [J].
Betz, UAK ;
Bloch, W ;
van den Broek, M ;
Yoshida, K ;
Taga, T ;
Kishimoto, T ;
Addicks, K ;
Rajewsky, K ;
Müller, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1955-1965
[7]   Crystal structure of a cytokine-binding region of gp130 [J].
Bravo, J ;
Staunton, D ;
Heath, JK ;
Jones, EY .
EMBO JOURNAL, 1998, 17 (06) :1665-1674
[8]   Structure of an extracellular gp130 cytokine receptor signaling complex [J].
Chow, DC ;
He, XL ;
Snow, AL ;
Rose-John, S ;
Garcia, KC .
SCIENCE, 2001, 291 (5511) :2150-2155
[9]   MICE LACKING THE CNTF RECEPTOR, UNLIKE MICE LACKING CNTF, EXHIBIT PROFOUND MOTOR-NEURON DEFICITS AT BIRTH [J].
DECHIARA, TM ;
VEJSADA, R ;
POUEYMIROU, WT ;
ACHESON, A ;
SURI, C ;
CONOVER, JC ;
FRIEDMAN, B ;
MCCLAIN, J ;
PAN, L ;
STAHL, N ;
IP, NY ;
KATO, A ;
YANCOPOULOS, GD .
CELL, 1995, 83 (02) :313-322
[10]   DEVELOPMENT OF AN INTERLEUKIN (IL)-6 RECEPTOR ANTAGONIST THAT INHIBITS IL-6-DEPENDENT GROWTH OF HUMAN MYELOMA CELLS [J].
DEHON, FD ;
EHLERS, M ;
ROSEJOHN, S ;
EBELING, SB ;
BOS, HK ;
AARDEN, LA ;
BRAKENHOFF, JPJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2395-2400